Pharmacokinetics of moxidectin in alpacas following administration of an oral or subcutaneous formulation

Research in Veterinary Science

Volumn 105, Issue , 2016, Pages 160-164

  Cocquyt, Christine M ^a,b   Van Amstel, Sarel ^a   Cox, Sherry ^a   Rohrbach, Barton ^a   Martín Jiménez, Tomás ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Tennessee Equine Hospital   (United States)

Author keywords

Alpaca; Anthelmintic; Camelid; Moxidectin; Pharmacokinetics

Indexed keywords

MOXIDECTIN; ANTINEMATODAL AGENT; MACROLIDE; MILBEMYCIN;

ALPACA; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BIOAVAILABILITY; DRUG EFFECTS; HAEMONCHIASIS; HAEMONCHUS; HALF LIFE TIME; MALE; NEW WORLD CAMELID; ORAL DRUG ADMINISTRATION; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VETERINARY;

ADMINISTRATION, ORAL; ANIMALS; ANTINEMATODAL AGENTS; BIOLOGICAL AVAILABILITY; CAMELIDS, NEW WORLD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HAEMONCHIASIS; HAEMONCHUS; HALF-LIFE; INJECTIONS, SUBCUTANEOUS; MACROLIDES; MALE;

EID: 84959208440     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2015.12.011     Document Type: Article

References (18)

1. Almeida F.A., Garcia K.C.O.D., Torgenson P.R., Amarante A.F.T. Multiple resistance to anthelmintics by Haemonchus contortus and Trichostrongylus colubriformis in sheep in Brazil. Parasitol. Int. 2010, 59:622-625.
2. Alvinerie M., Sutra J.F., Badri M., Galtier P. Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection. J. Chromatogr. B 1995, 674:119-124.
3. Alvinerie M., Escudero E., Sutra J., Eeckhoutte C., Galtier P. The pharmacokinetics of moxidectin after oral and subcutaneous administration to sheep. Vet. Res. 1998, 29:113-118.
4. Alvinerie M., Sutra J.F., Cabezas I., Rubilar L., Perez R. Enhanced plasma availability of moxidectin in fasted horses. Journal of Equine Veterinary Science 2000, 20:575-578.
5. Barber S., Bowles V., Lespine A., Alvinerie M. The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep. J. Vet. Pharmacol. Ther. 2003, 26:343-348.
6. Bassissi M.F., Alvinerie M., Martin P.G.P., Perret B., Lespine A. Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics. Pharm. Res. 2006, 23:2672-2680.
7. Craven J., Bjørn H., Hennessy D.R., Friis C. The effects of body composition on the pharmacokinetics of subcutaneously injected ivermectin and moxidectin in pigs. J. Vet. Pharmacol. Ther. 2002, 25:227-232.
8. Escudero E., Carceles C.M., Diaz M.S., Sutra J.F., Galtier P., Alvinerie M. Pharmacokinetics of moxidectin and doramectin in goats. Res. Vet. Sci. 1999, 67:175-179.
9. Gillespie R.M., Williamson L.H., Terrill T.H., Kaplan R.M. Efficacy of anthelmintics on South American camelid (llama and alpaca) farms in Georgia. Vet. Parasitol. 2010, 172:168-171.
10. Hunter R., Isaza R., Koch D., Dodd C., Goately M. Moxidectin plasma concentrations following topical administration to llamas (Lama glama) and alpacas (Lama pacos). Small Rumin. Res. 2004, 52:275-279.
11. Jarvinen J.A., Miller J.A., Oehler D.D. Pharmacokinetics of ivermectin in llamas (Lama glama). Veterinary Record 2002, 150:344-346.
12. Lanusse C., Lifschitz A., Virkel G., Alvarez L., Sánchez S., Sutra J.F., Galtier P., Alvinerie M. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J. Vet. Pharmacol. Ther. 1997, 20:91-99.
13. Lespine A., Sutra J., Dupuy J., Alvinerie M., Aumont G. The influence of parasitism on the pharmacokinetics of moxidectin in lambs. Parasitol. Res. 2004, 93:121-126.
14. Lifschitz A., Virkel G., Imperiale F., Sutra J.F., Galtier P., Lanusse C., Alvinerie M. Moxidectin in cattle: correlation between plasma and target tissues disposition. J. Vet. Pharmacol. Ther. 1999, 22:266-273.
15. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Pis A., Lanusse C. Moxidectin and ivermectin metabolic stability in sheep ruminal and abomasal contents. J. Vet. Pharmacol. Ther. 2005, 28:411-418.
16. Oukessou M., Sutra J., Galtier P., Alvinerie M. Plasma and milk pharmacokinetics of moxidectin in the camel (Camelus dromedaries). J. Vet. Pharmacol. Ther. 1997, 20:81.
17. Oukessou M., Berrag B., Alvinerie M. A comparative kinetic study of ivermectin and moxidectin in lactating camels (Camelus dromedaries). Veterinary Parasitology 1999, 83:151-159.
18. Perez R., Cabezas I., Garcia M., Rubilar L., Sutra J.F., Galtier P., Alvineria M. Comparison of the pharmacokinetics of moxidectin (Equest) and ivermectin (Eqvalan) in horses. J. Vet. Pharmacol. Ther. 1999, 22:174-180.